Exclusion of aldose reductase as a mediator of ERG deficits in a mouse model of diabetic eye disease

Visual Neuroscience

Volumn 29, Issue 6, 2012, Pages 267-274

  Samuels, Ivy S ^a,b   Lee, Chieh Allen ^c   Petrash, J Mark ^d   Peachey, Neal S ^a,b,c   Kern, Timothy S ^a,c  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Aldose reductase; c wave; Diabetes; Diabetic retinopathy; Electroretinogram; Outer retina; Retinal pigment epithelium

Indexed keywords

ALDEHYDE REDUCTASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

A WAVE; ANIMAL EXPERIMENT; ANIMAL MODEL; B WAVE; C WAVE; CONTROLLED STUDY; DIABETIC RETINOPATHY; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; ENZYME INACTIVATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIGHT; LUMINANCE; MALE; MOUSE; NONHUMAN; OSCILLATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA NEUROEPITHELIAL LAYER; REVIEW; STREPTOZOCIN DIABETES;

ALDEHYDE REDUCTASE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RETINAL PIGMENT EPITHELIUM; STREPTOZOCIN;

EID: 84870830408     PISSN: 09525238     EISSN: 14698714     Source Type: Journal    
DOI: 10.1017/S0952523812000326     Document Type: Review

References (72)

1. Aizu, Y., Katayama, H., Takahama, S., Hu, J., Nakagawa, H. & Oyanagi, K. (2003). Topical instillation of ciliary neurotrophic factor inhibits retinal degeneration in streptozotocin-induced diabetic rats. Neuroreport 14, 2067-2071.
2. Alvarez, Y., Chen, K., Reynolds, A.L., Waghorne, N., O'Connor, J.J. & Kennedy, B.N. (2010). Predominant cone photoreceptor dysfunction in a hyperglycaemic model of non-proliferative diabetic retinopathy. Disease Models and Mechanisms 3, 236-245.
3. Arden, G.B. & Constable, P.A. (2006). The electro-oculogram. Progress in Retinal and Eye Research 25, 207-248.
4. Arnal, E., Miranda, M., Johnsen-Soriano, S., Alvarez-Nolting, R., Diaz-Llopis, M., Araiz, J., Cervera, E., Bosch-Morell, F. & Romero, F.J. (2009). Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Current Eye Research 34, 928-938.
5. Ashizawa, N., Yoshida, M., Sugiyama, Y., Akaike, N., Ohbayashi, S., Aotsuka, T., Abe, N., Fukushima, K. & Matsuura, A. (1997). Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats. Japanese Journal of Pharmacology 73, 133-144.
6. Barile, G.R., Rachydaki, S.I., Tari, S.R., Lee, S.E., Donmoyer, C.M., Ma, W., Rong, L.L., Buciarelli, L.G., Wendt, T., Horig, H., Hudson, B.I., Qu, W., Weinberg, A.D., Yan, S.F. & Schmidt, A.M. (2005). The RAGE axis in early diabetic retinopathy. Investigative Ophthalmology and Visual Science 46, 2916-2924.
7. Barski, O.A., Tipparaju, S.M. & Bhatnagar, A. (2008). The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Drug Metabolism Reviews 40, 553-624.
8. Biersdorf, W.R., Malone, J.I., Pavan, P.R. & Lowitt, S. (1988). Cone electroretinograms and visual acuities of diabetic patients on sorbinil treatment. Documenta Ophthalmologica 69, 247-254.
9. Biro, K., Palhalmi, J., Toth, A.J., Kukorelli, T. & Juhasz, G. (1998). Bimoclomol improves early electrophysiological signs of retinopathy in diabetic rats. Neuroreport 9, 2029-2033.
10. Bresnick, G.H., Korth, K., Groo, A. & Palta, M. (1984). Electroretino-graphic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Archives of Ophthalmology 102, 1307-1311.
11. Bresnick, G.H. & Palta, M. (1987). Oscillatory potential amplitudes. Relation to severity of diabetic retinopathy. Archives of Ophthalmology 105, 929-933.
12. Bui, B.V., Armitage, J.A., Tolcos, M., Cooper, M.E. & Vingrys, A.J. (2003). ACE inhibition salvages the visual loss caused by diabetes. Diabetologia 46, 401-408.
13. Centers for Disease Control and Prevention. (2011). National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
14. Coupland, S.G. (1987). A comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy. Documenta Oph-thalmologica 66, 207-218.
15. - conductance in toad retinal pigment epithelium. The American Journal of Physiology 262, C374-383.
16. Funada, M., Okamoto, I., Fujinaga, Y. & Yamana, T. (1987). Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats. Japanese Journal of Ophthalmology 31, 305-314.
17. Gallemore, R.P. & Steinberg, R.H. (1989). Effects of DIDS on the chick retinal pigment epithelium. II. Mechanism of the light peak and other responses originating at the basal membrane. The Journal of Neuroscience 9, 1977-1984.
18. Gallemore, R.P. & Steinberg, R.H. (1993). Light-evoked modulation of basolateral membrane Cl-conductance in chick retinal pigment epithelium: The light peak and fast oscillation. Journal of Neurophysiology 70, 1669-1680.
19. Griff, E.R. & Steinberg, R.H. (1984). Changes in apical [K+] produce delayed basal membrane responses of the retinal pigment epithelium in the gecko. The Journal of General Physiology 83, 193-211.
20. Hancock, H.A. & Kraft, T.W. (2004). Oscillatory potential analysis and ERGs of normal and diabetic rats. Investigative Ophthalmology and Visual Science 45, 1002-1008.
21. Hardy, K.J., Fisher, C., Heath, P., Foster, D.H. & Scarpello, J.H. (1995). Comparison of colour discrimination and electroretinography in evaluation of visual pathway dysfunction in aretinopathic IDDM patients. The British Journal of Ophthalmology 79, 35-37.
22. Hers, H.G. (1962). [Increase of activity of glucose-6-phosphatase in intolerance to fructose]. Revue Internationale d'Hepatologie 12, 777-782.
23. Ho, H.T., Chung, S.K., Law, J.W., Ko, B.C., Tam, S.C., Brooks, H.L., Knepper, M.A. & Chung, S.S. (2000). Aldose reductase-deficient mice develop nephrogenic diabetes insipidus. Molecular and Cellular Biology 20, 5840-5846.
24. Holopigian, K., Seiple, W., Lorenzo, M. & Carr, R. (1992). A comparison of photopic and scotopic electroretinographic changes in early diabetic retinop-athy. Investigative Ophthalmology and Visual Science 33, 2773-2780.
25. Hotta, N. (1995). New approaches for treatment in diabetes: Aldose reductase inhibitors. Biomedicine and Pharmacotherapy 49, 232-243.
26. Hotta, N., Koh, N., Sakakibara, F., Nakamura, J., Hamada, Y., Hara, T., Fukasawa, H., Kakuta, H. & Sakamoto, N. (1996). Effect of propionyl-L-carnitine on oscillatory potentials in electroretinogram in streptozotocin-diabetic rats. European Journal of Pharmacology 311, 199-206.
27. Hotta, N., Koh, N., Sakakibara, F., Nakamura, J., Hamada, Y., Hara, T., Takeuchi, N., Inukai, S., Kasama, N., Fukasawa, H. & Kakuta, H. (1995a).An aldose reductase inhibitor, TAT, prevents electroretinographic abnormalities and ADP-induced hyperaggregability in streptozotocin-induced diabetic rats. European Journal of Clinical Investigation 25, 948-954.
28. Hotta, N., Koh, N., Sakakibara, F., Nakamura, J., Hamada, Y., Naruse, K., Sasaki, H., Mizuno, K., Matsubara, A., Kakuta, H., Fukasawa, H. & Sakamoto, N. (1995b). Effect of an aldose reductase inhibitor, SNK-860, on deficits in the electroretinogram of diabetic rats. Experimental Physiology 80, 981-989.
29. Hotta, N., Koh, N., Sakakibara, F., Nakamura, J., Hara, T., Hamada, Y., Fukasawa, H., Kakuta, H. & Sakamoto, N. (1997). Effect of an aldose reductase inhibitor on abnormalities of electroretinogram and vascular factors in diabetic rats. European Journal of Pharmacology 326, 45-51.
30. Johnsen-Soriano, S., Garcia-Pous, M., Arnal, E., Sancho-Tello, M., Garcia-Delpech, S., Miranda, M., Bosch-Morell, F., Diaz-Llopis, M., Navea, A. & Romero, F.J. (2008). Early lipoic acid intake protects retina of diabetic mice. Free Radical Research 42, 613-617.
31. Juen, S. & Kieselbach, G.F. (1990). Electrophysiological changes in juvenile diabetics without retinopathy. Archives of Ophthalmology 108, 372-375.
32. Kofuji, P., Ceelen, P., Zahs, K.R., Surbeck, L.W., Lester, H.A. & Newman, E.A. (2000). Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: Phenotypic impact in retina. The Journal of Neuroscience 20, 5733-5740.
33. Levin, R.D., Kwaan, H.C., Dobbie, J.G., Fetkenhour, C.L., Traisman, H.S. & Kramer, C. (1982). Studies of retinopathy and the plasma co-factor of platelet hyperaggregation in type 1 (insulin-dependent) diabetic children. Diabetologia 22, 445-449.
34. Linsenmeier, R.A. & Steinberg, R.H. (1982). Origin and sensitivity of the light peak in the intact cat eye. The Journal of Physiology 331, 653-673.
35. Lovasik, J.V. & Spafford, M.M. (1988). An electrophysiological investigation of visual function in juvenile insulin-dependent diabetes mellitus. American Journal of Optometry and Physiological Optics 65, 236-253.
36. Lowitt, S., Malone, J.I., Salem, A., Kozak, W.M. & Orfalian, Z. (1993). Acetyl-L-carnitine corrects electroretinographic deficits in experimental diabetes. Diabetes 42, 1115-1118.
37. MacGregor, L.C. & Matschinsky, F.M. (1985). Treatment with aldose reductase inhibitor or with myo-inositol arrests deterioration of the electroretinogram of diabetic rats. The Journal of Clinical Investigation 76, 887-889.
38. MacGregor, L.C. & Matschinsky, F.M. (1986). Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium. Metabolism: Clinical and Experimental 35, 28-34.
39. MacGregor, L.C., Rosecan, L.R., Laties, A.M. & Matschinsky, F.M. (1986). Altered retinal metabolism in diabetes. I. Microanalysis of lipid, glucose, sorbitol, and myo-inositol in the choroid and in the individual layers of the rabbit retina. The Journal of Biological Chemistry 261, 4046-4051.
40. Matsui, T., Nakamura, Y., Ishikawa, H., Matsuura, A. & Kobayashi, F. (1994). Pharmacological profiles of a novel aldose reductase inhibitor, SPR-210, and its effects on streptozotocin-induced diabetic rats. Japanese Journal of Pharmacology 64, 115-124.
41. Nakamura, J., Kato, K., Hamada, Y., Nakayama, M., Chaya, S., Nakashima, E., Naruse, K., Kasuya, Y., Mizubayashi, R., Miwa, K., Yasuda, Y., Kamiya, H., Ienaga, K., Sakakibara, F., Koh, N. & Hotta, N. (1999). A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 48, 2090-2095.
42. Nanasi, P.P. & Jednakovits, A. (2001). Multilateral in vivo and in vitro protective effects of the novel heat shock protein coinducer, bimoclomol: Results of preclinical studies. Cardiovascular Drug Reviews 19, 133-151.
43. Oakley, B. II. & Green, D.G. (1976). Correlation of light-induced changes in retinal extracellular potassium concentration with c-wave of the electroretinogram. Journal of Neurophysiology 39, 1117-1133.
44. Pautler, E.L. & Ennis, S.R. (1980). The effect of induced diabetes on the electroretinogram components of the pigmented rat. Investigative Ophthalmology and Visual Science 19, 702-705.
45. Phipps, J.A. & Feener, E.P. (2008). The kallikrein-kinin system in diabetic retinopathy: Lessons for the kidney. Kidney International 73, 1114-1119.
46. Phipps, J.A., Fletcher, E.L. & Vingrys, A.J. (2004). Paired-flash identification of rod and cone dysfunction in the diabetic rat. Investigative Ophthalmology and Visual Science 45, 4592-4600.
47. Phipps, J.A., Yee, P., Fletcher, E.L. & Vingrys, A.J. (2006). Rod photoreceptor dysfunction in diabetes: Activation, deactivation, and dark adaptation. Investigative Ophthalmology and Visual Science 47, 3187-3194.
48. Samuels, I.S., Sturgill, G.M., Grossman, G.H., Rayborn, M.E., Hollyfield, J.G. & Peachey, N.S. (2010). Light-evoked responses of the retinal pigment epithelium: Changes accompanying photore-ceptor loss in the mouse. Journal of Neurophysiology 104, 391-402.
49. Schmidt, R. & Steinberg, R.H. (1971). Rod-dependent intracellular responses to light recorded from the pigment epithelium of the cat retina. The Journal of Physiology 217, 71-91.
50. Schneck, M.E., Fortune, B. & Adams, A.J. (2000). The fast oscillation of the electrooculogram reveals sensitivity of the human outer retina/retinal pigment epithelium to glucose level. Vision Research 40, 3447-3453.
51. Schneck, M.E., Shupenko, L. & Adams, A.J. (2008). The fast oscillation of the EOG in diabetes with and without mild retinopathy. Documenta Ophthalmologica 116, 231-236.
52. Shirao, Y. & Kawasaki, K. (1998). Electrical responses from diabetic retina. Progress in Retinal and Eye Research 17, 59-76.
53. Simo, R. & Hernandez, C. (2009). Advances in the medical treatment of diabetic retinopathy. Diabetes Care 32, 1556-1562.
54. Steinberg, R.H. (1985). Interactions between the retinal pigment epithelium and the neural retina. Documenta Ophthalmologica 60, 327-346.
55. Steinberg, R.H. & Miller, S. (1973). Aspects of electrolyte transport in frog pigment epithelium. Experimental Eye Research 16, 365-372.
56. Steinberg, R.H., Schmidt, R. & Brown, K.T. (1970). Intracellular responses to light from cat pigment epithelium: Origin of the electro-retinogram c-wave. Nature 227, 728-730.
57. Strauss, O. (2005). The retinal pigment epithelium in visual function. Physiological Reviews 85, 845-881.
58. Tzekov, R. & Arden, G.B. (1999). The electroretinogram in diabetic retinopathy. Survey of Ophthalmology 44, 53-60.
59. Villarroel, M., Garcia-Ramirez, M., Corraliza, L., Hernandez, C. & Simo, R. (2009a). Effects of high glucose concentration on the barrier function and the expression of tight junction proteins in human retinal pigment epithelial cells. Experimental Eye Research 89, 913-920.
60. Villarroel, M., Garcia-Ramirez, M., Corraliza, L., Hernandez, C. & Simo, R. (2009b). High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells. Endocrinologia y Nutricion 56, 53-58.
61. Vinores, S.A., Derevjanik, N.L., Ozaki, H., Okamoto, N. & Campochiaro, P.A. (1999). Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Documenta Ophthalmologica 97, 217-228.
62. Wang, J., Xu, X., Elliott, M.H., Zhu, M. & Le, Y.Z. (2010). Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 59, 2297-2305.
63. Witkovsky, P., Dudek, F.E. & Ripps, H. (1975). Slow PIII component of the carp electroretinogram. The Journal of General Physiology 65, 119-134.
64. Wong, V.H., Bui, B.V. & Vingrys, A.J. (2011). Clinical and experimental links between diabetes and glaucoma. Clinical and Experimental Optometry 94, 4-23.
65. Wu, J., Marmorstein, A.D., Kofuji, P. & Peachey, N.S. (2004a). Contribution of Kir4.1 to the mouse electroretinogram. Molecular Vision 10, 650-654.
66. Wu, J., Peachey, N.S. & Marmorstein, A.D. (2004b). Light-evoked responses of the mouse retinal pigment epithelium. Journal of Neuro-physiology 91, 1134-1142.
67. Xu, H.Z. & Le, Y.Z. (2011). Significance of outer blood-retina barrier breakdown in diabetes and ischemia. Investigative Ophthalmology and Visual Science 52, 2160-2164.
68. Xu, H.-Z., Song, Z., Fu, S., Zhu, M. & Le, Y.-Z. (2011). RPE barrier breakdown in diabetic retinopathy: Seeing is believing. Journal of Ocular Biology, Diseases, and Informatics 4, 83-92.
69. Yee, P., Weymouth, A.E., Fletcher, E.L. & Vingrys, A.J. (2010). A role for omega-3 polyunsaturated fatty acid supplements in diabetic neuropathy. Investigative Ophthalmology and Visual Science 51, 1755-1764.
70. Yonemura, D (1978). Electrophysiological study on activities of neuronal and non-neuronal retinal elements in man with reference to its clinical application. Japanese Journal of Ophthalmology 22, 195-213.
71. Yonemura, D., Aoki, T. & Tsuzuki, K. (1962). Electroretinogram in diabetic retinopathy. Archives of Ophthalmology 68, 19-24.
72. Zheng, L., Du, Y., Miller, C., Gubitosi-Klug, R.A., Kern, T.S., Ball, S. & Berkowitz, B.A. (2007). Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia 50, 1987-1996.